Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATPase-coupled lipid transmembrane transporter activity	ABCC1 ABCG4 ABCG1	1.30e-05	9	109	3	GO:0034040
GeneOntologyMolecularFunction	ABC-type sterol transporter activity	ABCG4 ABCG1	2.95e-05	2	109	2	GO:0034041
GeneOntologyMolecularFunction	histone H3K9 acetyltransferase activity	KAT2A KAT2B	8.83e-05	3	109	2	GO:0043992
GeneOntologyMolecularFunction	Gq/11-coupled serotonin receptor activity	HTR2A HTR2B	8.83e-05	3	109	2	GO:0001587
GeneOntologyMolecularFunction	retinoic acid binding	LRAT UGT2B15 UGT2B17	4.69e-04	28	109	3	GO:0001972
GeneOntologyMolecularFunction	organic hydroxy compound transmembrane transporter activity	SLC10A4 ABCG4 ABCG1 SLC18A1	5.84e-04	70	109	4	GO:1901618
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	ABCC1 SLC10A4 ABCG4 ABCG1	6.85e-04	73	109	4	GO:0170055
GeneOntologyBiologicalProcess	organophosphate metabolic process	LRAT FMO2 HTR2A HTR2B PDHB IDH3A PFKL NUDT17 GFPT1 ADCY8 PDXK LPIN1 PARP1 KAT2B ADSL GUCY1A2 FIG4 SERAC1 RD3	5.94e-06	1142	107	19	GO:0019637
GeneOntologyBiologicalProcess	phospholipase C-activating serotonin receptor signaling pathway	HTR2A HTR2B	7.97e-05	3	107	2	GO:0007208
GeneOntologyBiologicalProcess	positive regulation of phosphatidylinositol biosynthetic process	HTR2A HTR2B	7.97e-05	3	107	2	GO:0010513
GeneOntologyBiologicalProcess	purine nucleotide metabolic process	FMO2 HTR2A PDHB IDH3A PFKL NUDT17 ADCY8 PARP1 KAT2B ADSL GUCY1A2 RD3	8.85e-05	619	107	12	GO:0006163
GeneOntologyBiologicalProcess	pyridine-containing compound metabolic process	FMO2 HTR2A IDH3A PFKL NUDT17 PDXK KAT2B	1.13e-04	210	107	7	GO:0072524
GeneOntologyBiologicalProcess	organophosphate biosynthetic process	HTR2A HTR2B PDHB ADCY8 PDXK LPIN1 PARP1 ADSL GUCY1A2 FIG4 SERAC1 RD3	1.28e-04	644	107	12	GO:0090407
GeneOntologyBiologicalProcess	purine-containing compound metabolic process	FMO2 HTR2A PDHB IDH3A PFKL NUDT17 ADCY8 PARP1 KAT2B ADSL GUCY1A2 RD3	1.44e-04	652	107	12	GO:0072521
GeneOntologyBiologicalProcess	cellular response to high density lipoprotein particle stimulus	ABCG4 ABCG1	1.59e-04	4	107	2	GO:0071403
GeneOntologyBiologicalProcess	nucleobase-containing small molecule metabolic process	FMO2 HTR2A PDHB IDH3A PFKL NUDT17 GFPT1 ADCY8 PARP1 KAT2B ADSL GUCY1A2 RD3	1.70e-04	767	107	13	GO:0055086
GeneOntologyBiologicalProcess	nucleotide metabolic process	FMO2 HTR2A PDHB IDH3A PFKL NUDT17 ADCY8 PARP1 KAT2B ADSL GUCY1A2 RD3	2.24e-04	684	107	12	GO:0009117
GeneOntologyBiologicalProcess	nucleoside phosphate metabolic process	FMO2 HTR2A PDHB IDH3A PFKL NUDT17 ADCY8 PARP1 KAT2B ADSL GUCY1A2 RD3	2.46e-04	691	107	12	GO:0006753
GeneOntologyBiologicalProcess	negative regulation of purine nucleotide biosynthetic process	PARP1 RD3	2.64e-04	5	107	2	GO:1900372
GeneOntologyBiologicalProcess	male genitalia morphogenesis	AR SYCP2	2.64e-04	5	107	2	GO:0048808
GeneOntologyBiologicalProcess	negative regulation of nucleotide biosynthetic process	PARP1 RD3	2.64e-04	5	107	2	GO:0030809
GeneOntologyBiologicalProcess	male anatomical structure morphogenesis	AR SYCP2	2.64e-04	5	107	2	GO:0090598
GeneOntologyBiologicalProcess	regulation of phosphatidylinositol biosynthetic process	HTR2A HTR2B	2.64e-04	5	107	2	GO:0010511
Domain	ABCG1	ABCG4 ABCG1	3.31e-05	2	108	2	IPR020064
Domain	PCAF_N	KAT2A KAT2B	3.31e-05	2	108	2	IPR009464
Domain	Hist_acetylase_PCAF	KAT2A KAT2B	3.31e-05	2	108	2	IPR016376
Domain	PCAF_N	KAT2A KAT2B	3.31e-05	2	108	2	PF06466
Domain	GSCR1_dom	BICRA BICRAL	3.31e-05	2	108	2	IPR015671
Domain	GLTSCR1	BICRA BICRAL	3.31e-05	2	108	2	PF15249
Domain	ABC_2_trans	ABCG4 ABCG1	3.28e-04	5	108	2	IPR013525
Domain	ABC2_membrane	ABCG4 ABCG1	3.28e-04	5	108	2	PF01061
Domain	ARM-type_fold	IPO5 NOC3L FRYL UNC45A SF3B1 NOM1 NBEAL2 SERAC1	7.91e-04	339	108	8	IPR016024
Domain	Calx_beta	FREM3 FREM2	9.07e-04	8	108	2	SM00237
Domain	ARM-like	IPO5 NOC3L FRYL UNC45A SF3B1 NBEAL2 SERAC1	9.83e-04	270	108	7	IPR011989
Domain	Calx_beta	FREM3 FREM2	1.16e-03	9	108	2	IPR003644
Domain	Calx-beta	FREM3 FREM2	1.16e-03	9	108	2	PF03160
Domain	5HT_rcpt	HTR2A HTR2B	1.16e-03	9	108	2	IPR002231
Domain	-	UNC45A INTS8 NAA25 CFAP54 TTC29 KLC1	1.29e-03	207	108	6	1.25.40.10
Domain	AAA+_ATPase	ABCC1 DNAH3 ABCG4 ABCG1 DNAH12	1.50e-03	144	108	5	IPR003593
Domain	AAA	ABCC1 DNAH3 ABCG4 ABCG1 DNAH12	1.50e-03	144	108	5	SM00382
Domain	ABC_transporter_CS	ABCC1 ABCG4 ABCG1	1.83e-03	42	108	3	IPR017871
Domain	TPR-like_helical_dom	UNC45A INTS8 NAA25 CFAP54 TTC29 KLC1	2.35e-03	233	108	6	IPR011990
Domain	ABC_tran	ABCC1 ABCG4 ABCG1	2.69e-03	48	108	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC1 ABCG4 ABCG1	2.69e-03	48	108	3	PS50893
Domain	TPR_REGION	UNC45A INTS8 NAA25 TTC29 KLC1	2.72e-03	165	108	5	PS50293
Domain	TPR	UNC45A INTS8 NAA25 TTC29 KLC1	2.72e-03	165	108	5	PS50005
Domain	ABC_TRANSPORTER_1	ABCC1 ABCG4 ABCG1	2.86e-03	49	108	3	PS00211
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH12	2.88e-03	14	108	2	IPR024317
Domain	Dynein_heavy_dom-2	DNAH3 DNAH12	2.88e-03	14	108	2	IPR013602
Domain	G_DYNAMIN_dom	EHD1 DNM1	2.88e-03	14	108	2	IPR030381
Domain	DHC_N2	DNAH3 DNAH12	2.88e-03	14	108	2	PF08393
Domain	AAA_8	DNAH3 DNAH12	2.88e-03	14	108	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH12	2.88e-03	14	108	2	IPR011704
Domain	G_DYNAMIN_2	EHD1 DNM1	2.88e-03	14	108	2	PS51718
Domain	AAA_5	DNAH3 DNAH12	2.88e-03	14	108	2	PF07728
Domain	ABC_transporter-like	ABCC1 ABCG4 ABCG1	3.03e-03	50	108	3	IPR003439
Domain	DHC_fam	DNAH3 DNAH12	3.31e-03	15	108	2	IPR026983
Domain	Dynamin_GTPase	EHD1 DNM1	3.31e-03	15	108	2	IPR001401
Domain	Dynamin_N	EHD1 DNM1	3.31e-03	15	108	2	PF00350
Domain	Dynamin_SF	EHD1 DNM1	3.31e-03	15	108	2	IPR022812
Domain	Dynein_heavy_dom	DNAH3 DNAH12	3.31e-03	15	108	2	IPR004273
Domain	Dynein_heavy	DNAH3 DNAH12	3.31e-03	15	108	2	PF03028
Domain	A/G_cyclase_CS	ADCY8 GUCY1A2	4.26e-03	17	108	2	IPR018297
Domain	Nucleotide_cyclase	ADCY8 GUCY1A2	4.77e-03	18	108	2	IPR029787
Domain	-	ADCY8 GUCY1A2	4.77e-03	18	108	2	3.30.70.1230
Domain	GUANYLATE_CYCLASE_1	ADCY8 GUCY1A2	5.31e-03	19	108	2	PS00452
Domain	Guanylate_cyc	ADCY8 GUCY1A2	5.31e-03	19	108	2	PF00211
Domain	GUANYLATE_CYCLASE_2	ADCY8 GUCY1A2	5.31e-03	19	108	2	PS50125
Domain	A/G_cyclase	ADCY8 GUCY1A2	5.31e-03	19	108	2	IPR001054
Domain	CYCc	ADCY8 GUCY1A2	5.31e-03	19	108	2	SM00044
Pubmed	Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.	AR UGT2B15 UGT2B17	3.16e-08	3	111	3	18302198
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	IPO5 MYO1D MAP4 PDHB NOC3L UNC45A IDH3A PFKL ADAR GFPT1 PDXK STT3A FANCD2 PARP1 SF3B1 ADSL PMPCA CCAR1 UBE3C	1.24e-07	1425	111	19	30948266
Pubmed	Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.	AR UGT2B15 UGT2B17	1.26e-07	4	111	3	18281521
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	IPO5 ABCC1 MAP4 PDHB IDH3A PFKL GFPT1 STT3A PARP1 SF3B1 ADSL EHD1	3.03e-06	711	111	12	33022573
Pubmed	Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization.	ABCG4 ABCG1	1.01e-05	2	111	2	15240127
Pubmed	Transcriptional coactivator p300/CBP-associated factor and p300/CBP-associated factor type B are required for normal estrogen response of the mouse uterus.	KAT2A KAT2B	1.01e-05	2	111	2	15502373
Pubmed	Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptors.	HTR2A HTR2B	1.01e-05	2	111	2	24244317
Pubmed	Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.	HTR2A HTR2B	1.01e-05	2	111	2	16517693
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	1.01e-05	2	111	2	32660355
Pubmed	Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.	AR PARP1	1.01e-05	2	111	2	28851861
Pubmed	Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis.	KAT2A KAT2B	1.01e-05	2	111	2	11027331
Pubmed	Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network.	HTR2A HTR2B	1.01e-05	2	111	2	21789169
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	1.01e-05	2	111	2	1909870
Pubmed	Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activity.	KAT2A KAT2B	1.01e-05	2	111	2	34270849
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	1.01e-05	2	111	2	24121496
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	1.01e-05	2	111	2	24267955
Pubmed	KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer.	KAT2A AR	1.01e-05	2	111	2	34381019
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	1.01e-05	2	111	2	22170718
Pubmed	PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma.	PTCH1 PARP1	1.01e-05	2	111	2	18660545
Pubmed	CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery.	PARP1 CTCF	1.01e-05	2	111	2	18539602
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	1.01e-05	2	111	2	3105095
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	1.01e-05	2	111	2	17848572
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	1.01e-05	2	111	2	27496708
Pubmed	Gcn5 and PCAF negatively regulate interferon-β production through HAT-independent inhibition of TBK1.	KAT2A KAT2B	1.01e-05	2	111	2	25269644
Pubmed	Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.	KAT2A KAT2B	1.01e-05	2	111	2	28678170
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	1.01e-05	2	111	2	17698910
Pubmed	PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.	PARP1 CTCF	1.01e-05	2	111	2	29976663
Pubmed	SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA.	SERAC1 ATP2A1	1.01e-05	2	111	2	35235340
Pubmed	Functional Cooperativity between ABCG4 and ABCG1 Isoforms.	ABCG4 ABCG1	1.01e-05	2	111	2	27228027
Pubmed	Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation.	PARP1 CTCF	1.01e-05	2	111	2	20038529
Pubmed	5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.	HTR2A HTR2B	1.01e-05	2	111	2	23346101
Pubmed	Divergent functions of histone acetyltransferases KAT2A and KAT2B in keratinocyte self-renewal and differentiation.	KAT2A KAT2B	1.01e-05	2	111	2	37259855
Pubmed	Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.	HTR2A HTR2B	1.01e-05	2	111	2	15862800
Pubmed	Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5.	KAT2A KAT2B	1.01e-05	2	111	2	29555684
Pubmed	Serotonin receptors 5-HTR2A and 5-HTR2B are involved in cigarette smoke-induced airway inflammation, mucus hypersecretion and airway remodeling in mice.	HTR2A HTR2B	1.01e-05	2	111	2	31787571
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	1.01e-05	2	111	2	3117546
Pubmed	PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin at the Lamina Promote Oscillating Transcription.	PARP1 CTCF	1.01e-05	2	111	2	26321255
Pubmed	H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.	KAT2A AR	1.01e-05	2	111	2	35639349
Pubmed	LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL.	ABCG4 ABCG1	1.01e-05	2	111	2	16556852
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	1.01e-05	2	111	2	28228532
Pubmed	ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain.	ABCG4 ABCG1	1.01e-05	2	111	2	18039927
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	1.01e-05	2	111	2	15666817
Pubmed	Network organization of the human autophagy system.	IPO5 MAP4 UNC45A IDH3A PFKL GFPT1 PARP1 ADSL CCAR1	1.17e-05	437	111	9	20562859
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IPO5 DENND2A MYO1D MAP4 PDHB IDH3A PFKL ERBIN PDXK PARP1 SF3B1 GUCY1A2 SACS EHD1 DNM1 KLC1	1.27e-05	1431	111	16	37142655
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	MYO1D PDHB PFKL ADAR GFPT1 STT3A PARP1 ADSL NOM1 ATP2A1	1.40e-05	565	111	10	33567341
Pubmed	Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.	GFPT1 CLCN1 ATP2A1	1.72e-05	16	111	3	16717059
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	IPO5 MAP4 SMYD5 KAT2A UNC45A ADAR GFPT1 PDXK FANCD2 PARP1 SF3B1 CTCF CCAR1	2.19e-05	1014	111	13	32416067
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MAP4 PDHB NOC3L SMYD5 FRYL IDH3A PFKL ADAR ERBIN GFPT1 STT3A PARP1 NAA25 SF3B1 CCAR1	3.02e-05	1367	111	15	32687490
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	3.02e-05	3	111	2	19572376
Pubmed	Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers.	HTR2A HTR2B	3.02e-05	3	111	2	28258217
Pubmed	Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner.	AR KAT2B	3.02e-05	3	111	2	11328859
Pubmed	Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors.	FANCD2 SF3B1	3.02e-05	3	111	2	29030393
Pubmed	Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.	HTR2A HTR2B	3.02e-05	3	111	2	18703043
Pubmed	Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.	UGT2B15 UGT2B17	3.02e-05	3	111	2	26385605
Pubmed	ABCA1, ABCG1, and ABCG4 are distributed to distinct membrane meso-domains and disturb detergent-resistant domains on the plasma membrane.	ABCG4 ABCG1	3.02e-05	3	111	2	25302608
Pubmed	Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules.	PTCH1 AR	3.02e-05	3	111	2	11090455
Pubmed	Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication.	KAT2A KAT2B	3.02e-05	3	111	2	11956210
Pubmed	Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.	HTR2A HTR2B	3.02e-05	3	111	2	15831837
Pubmed	ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.	ABCG4 ABCG1	3.02e-05	3	111	2	27196068
Pubmed	Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.	KAT2A KAT2B	3.02e-05	3	111	2	18250157
Pubmed	The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.	HTR2A HTR2B	3.02e-05	3	111	2	7582481
Pubmed	KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification.	KAT2A KAT2B	3.02e-05	3	111	2	27796307
Pubmed	5-HT2 receptors facilitate JC polyomavirus entry.	HTR2A HTR2B	3.02e-05	3	111	2	24089568
Pubmed	Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development.	KAT2A KAT2B	3.02e-05	3	111	2	29174768
Pubmed	Sperm count and motility are quantitatively affected by functional polymorphisms of HTR2A, MAOA and SLC18A.	HTR2A SLC18A1	3.02e-05	3	111	2	29602729
Pubmed	Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis.	PTCH1 PARP1	3.02e-05	3	111	2	29254138
Pubmed	Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.	UGT2B15 UGT2B17	3.02e-05	3	111	2	26163549
Pubmed	Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.	HTR2A HTR2B	3.02e-05	3	111	2	19057895
Pubmed	Serotonin and the 5-HT(2B) receptor in the development of enteric neurons.	HTR2A HTR2B	3.02e-05	3	111	2	10627607
Pubmed	GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF action.	KAT2A KAT2B	3.02e-05	3	111	2	25426559
Pubmed	Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.	UGT2B15 UGT2B17	3.02e-05	3	111	2	20736324
Pubmed	miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.	AR KAT2B	3.02e-05	3	111	2	23095762
Pubmed	Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo.	HTR2A HTR2B	3.02e-05	3	111	2	10978843
Pubmed	Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.	UGT2B15 UGT2B17	3.02e-05	3	111	2	28882566
Pubmed	Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT2A and 5-HT2B receptors in chondrocytes.	HTR2A HTR2B	3.02e-05	3	111	2	29145495
Pubmed	Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding.	KAT2A KAT2B	3.02e-05	3	111	2	12374802
Pubmed	Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.	SOHLH2 CTCF	3.02e-05	3	111	2	21296871
Pubmed	Serotonin signals through a gut-liver axis to regulate hepatic steatosis.	HTR2A HTR2B	3.02e-05	3	111	2	30446669
Pubmed	Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma.	ACVR1 AR	3.02e-05	3	111	2	21617230
Pubmed	Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.	UGT2B15 UGT2B17	3.02e-05	3	111	2	17988216
Pubmed	CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.	AR CCAR1	3.02e-05	3	111	2	23887938
Pubmed	Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.	UGT2B15 UGT2B17	3.02e-05	3	111	2	23223495
Pubmed	Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells.	HTR2A HTR2B	3.02e-05	3	111	2	24570000
Pubmed	ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL.	ABCG4 ABCG1	3.02e-05	3	111	2	16902247
Pubmed	In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.	KAT2A KAT2B	3.02e-05	3	111	2	33894414
Pubmed	The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.	UGT2B15 UGT2B17	3.02e-05	3	111	2	30689982
Pubmed	ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2.	ABCG4 ABCG1	3.02e-05	3	111	2	17916878
Pubmed	Expression of Fraser syndrome genes in normal and polycystic murine kidneys.	FREM3 FREM2	3.02e-05	3	111	2	21993971
Pubmed	Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes.	HTR2A HTR2B	3.02e-05	3	111	2	1381232
Pubmed	A protein interaction landscape of breast cancer.	IPO5 ABCC1 BICRA NOC3L ERBIN PARP1 CTCF NOM1 EHD1 UBE3C	3.74e-05	634	111	10	34591612
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CCDC117 IPO5 PDHB UNC45A IDH3A ADAR PARP1 SF3B1 CCAR1 UBE3C	3.94e-05	638	111	10	33239621
Pubmed	Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.	HTR2A HTR2B ADCY8 CHRNB4 SLC18A1	3.97e-05	118	111	5	19156168
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	IPO5 MAP4 ERBIN ADCY8 ATP2A1 KLC1	4.00e-05	195	111	6	17110338
Pubmed	Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.	PAQR9 FMO2 ADCY8 SLC18A1 UGT2B15 UGT2B17	4.23e-05	197	111	6	21386911
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYO1D UNC45A IDH3A PFKL GFPT1 PDXK EHD1 UBR3 UBE3C ATP2A1	4.43e-05	647	111	10	26618866
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	IPO5 MYO1D MAP4 PDHB UNC45A PFKL ERBIN GFPT1 PARP1 SF3B1 ADSL CTCF DHX35 KLC1	4.44e-05	1247	111	14	27684187
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP4 NOC3L UNC45A PFKL ADAR ERBIN SNX29 GFPT1 PARP1 SF3B1 CTCF KLC1	4.53e-05	934	111	12	33916271
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	IPO5 MAP4 IDH3A ADAR GFPT1 STT3A PARP1 SF3B1 UBE3C KLC1	4.78e-05	653	111	10	33742100
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 MYO1D MAP4 NOC3L FRYL GFPT1 SF3B1 CTCF CCAR1 ZMYM3	4.78e-05	653	111	10	22586326
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	IPO5 DNAH3 MAP4 PDHB NOC3L PFKL INTS8 PARP1 NOM1 ATP2A1 KLC1	5.41e-05	803	111	11	36517590
Cytoband	4p11	SLC10A4 FRYL	2.57e-04	10	111	2	4p11
Cytoband	4q13	UGT2B15 UGT2B17	5.96e-04	15	111	2	4q13
Cytoband	Ensembl 112 genes in cytogenetic band chr4p11	SLC10A4 FRYL	9.64e-04	19	111	2	chr4p11
Cytoband	7q36.3	NOM1 UBE3C	1.54e-03	24	111	2	7q36.3
Cytoband	12q24.13	MAPKAPK5 NAA25	1.68e-03	25	111	2	12q24.13
Cytoband	13q13.3	FREM2 SOHLH2	2.25e-03	29	111	2	13q13.3
GeneFamily	Blood group antigens\|CD molecules\|ATP binding cassette subfamily G	ABCG4 ABCG1	1.68e-04	5	75	2	811
GeneFamily	5-hydroxytryptamine receptors, G protein-coupled	HTR2A HTR2B	1.29e-03	13	75	2	170
GeneFamily	ATAC complex	KAT2A KAT2B	1.29e-03	13	75	2	1058
GeneFamily	Dyneins, axonemal	DNAH3 DNAH12	2.22e-03	17	75	2	536
GeneFamily	Lysine acetyltransferases\|ATAC complex\|SAGA complex\|GCN5 related N-acetyltransferases	KAT2A KAT2B	2.22e-03	17	75	2	1059
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT2A KAT2B	2.22e-03	17	75	2	486
GeneFamily	GCN5 related N-acetyltransferases	KAT2A KAT2B	4.42e-03	24	75	2	1134
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	LRAT CFAP54 DNAH12 EFCAB12 TTC29 UGT2B17 PADI1	2.18e-07	171	109	7	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29 SEC14L4	3.71e-07	185	109	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	5.11e-07	194	109	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 MUC16 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.06e-07	199	109	7	2498237b9e895ca4826a3378d9d40989968df72b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 MUC16 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.06e-07	199	109	7	542ec45c931b40738df1f3777b00c83be33a514a
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DENND2A MUC16 ADCY8 CFAP54 SVOP PADI1	1.07e-06	136	109	6	27a41463e6f16deb5b1d4f17fefded9959038c07
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DENND2A MUC16 ADCY8 CFAP54 SVOP PADI1	1.07e-06	136	109	6	88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	5.09e-06	178	109	6	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	5.26e-06	179	109	6	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	5.60e-06	181	109	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.35e-06	185	109	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.35e-06	185	109	6	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	6.35e-06	185	109	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCC1 PTCH1 FREM2 ABCG1 NRXN3 CACNA1I	6.75e-06	187	109	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.75e-06	187	109	6	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.96e-06	188	109	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	6.96e-06	188	109	6	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	droplet-Marrow-BM-1m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IPO5 SMYD5 KAT2A PDXK NAA25 ADSL	7.18e-06	189	109	6	b81540e097e95158851e07bfd78640ed6e64c2cf
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	7.18e-06	189	109	6	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	7.18e-06	189	109	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	7.18e-06	189	109	6	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IPO5 SMYD5 KAT2A PDXK NAA25 ADSL	7.18e-06	189	109	6	0fda1a3f1e87fadf5309c8267beaa4501983b1dd
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	7.18e-06	189	109	6	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	7.18e-06	189	109	6	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B AR ADCY8 FREM2 CFAP54 NRXN3	7.40e-06	190	109	6	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	7.62e-06	191	109	6	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	7.62e-06	191	109	6	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	7.62e-06	191	109	6	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	7.85e-06	192	109	6	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	8.33e-06	194	109	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	8.33e-06	194	109	6	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH3 MUC16 ECT2L CFAP54 DNAH12 TTC29	8.33e-06	194	109	6	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 MYO1D ECT2L CFAP54 DNAH12 TTC29	8.58e-06	195	109	6	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 MYO1D ECT2L CFAP54 DNAH12 TTC29	8.58e-06	195	109	6	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	8.83e-06	196	109	6	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	INTS8 PRDM11 CLCN1 ZMIZ2 SEC14L4 PADI1	9.09e-06	197	109	6	e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC10A4 ABCG4 NRXN3 CACNA1I DNM1 SVOP	9.91e-06	200	109	6	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Biopsy_Control_(H.)-Epithelial-Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	9ae434c78e08adf95da49c85616e3ca72d1227bf
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC10A4 ABCG4 NRXN3 CACNA1I DNM1 SVOP	9.91e-06	200	109	6	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	Biopsy_Other_PF-Epithelial-Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	721371698bce8890853fb6b6b01a2c20293b39e9
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L DNAH12 EFCAB12 TTC29 SEC14L4	9.91e-06	200	109	6	af6a551f83808c1c839df7ba7b1702ca28ea6e1b
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	e1dce91c6c531bb212002a14705e496d77ad3490
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L DNAH12 EFCAB12 TTC29 SEC14L4	9.91e-06	200	109	6	73ac1cf40ddd764be1100cbfaaa29563665457d8
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC10A4 ABCG4 NRXN3 CACNA1I DNM1 SVOP	9.91e-06	200	109	6	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 ECT2L CFAP54 DNAH12 EFCAB12 TTC29	9.91e-06	200	109	6	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Substantia_nigra-Macroglia-CSF_related\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH3 ECT2L DNAH12 TTC29 RD3	2.13e-05	136	109	5	47663c5d81c766a333207a44fc5b58b07309ee76
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH3 ECT2L DNAH12 TTC29 RD3	2.13e-05	136	109	5	6d2e5b871f4cf8d64e6fe0be666fb3490797c635
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH3 ECT2L DNAH12 TTC29 RD3	2.13e-05	136	109	5	fd4269d194c7c11c6ab4383393a01efab05cbace
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH3 ECT2L DNAH12 TTC29 RD3	2.13e-05	136	109	5	3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DNAH3 ECT2L DNAH12 TTC29 RD3	2.13e-05	136	109	5	67d736096d6b6ddb4722809557f5e987063b8d23
ToppCell	TCGA-Peripheral_Nervous_System\|World / Sample_Type by Project: Shred V9	SLC10A4 CHRNB4 SLC18A1 SVOP RD3	2.80e-05	144	109	5	3bbadb4b07ffb461d5400a5d69ad3b259f74041e
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 MUC16 CFAP54 DNAH12 TTC29	3.51e-05	151	109	5	8216462e723fec2797387929dde095370947e10a
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 NUDT17 EPG5 CDNF ZMYM3	4.91e-05	162	109	5	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	DNAH3 MUC16 ECT2L CFAP54 DNAH12	5.68e-05	167	109	5	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP54 DNAH12 EFCAB12 TTC29	6.01e-05	169	109	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 CFAP54 DNAH12 SEC14L4	6.01e-05	169	109	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	LRAT ABCG1 CFAP54 SACS DNM1	6.53e-05	172	109	5	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	FMO2 MUC16 ECT2L DNAH12 PADI1	6.53e-05	172	109	5	6b8a8d3b97c10b9d092307eed3cacbd2745df185
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO2 G0S2 NUDT17 EHD1 ATP2A1	6.71e-05	173	109	5	c63a615998d13b1725b5767f4ad2ec7e2b61db68
ToppCell	PCW_10-12-Epithelial-Epithelial_ciliated\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DNAH3 DNAH12 TTC29 UGT2B17 SEC14L4	6.89e-05	174	109	5	b8d1c556290d188f56aeefc17f03119686945fe7
ToppCell	PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DNAH3 DNAH12 TTC29 UGT2B17 SEC14L4	6.89e-05	174	109	5	00cf27bc23af1472a507be31fba6245a8fdd901b
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ABCC1 G0S2 EPG5 PRDM11 UBE3C	7.08e-05	175	109	5	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IPO5 G0S2 NOC3L NOM1 NBEAL2	7.47e-05	177	109	5	2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1
ToppCell	P03-Epithelial-airway_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 CFAP54 DNAH12 EFCAB12 TTC29	8.30e-05	181	109	5	1ea21d860d4d7abab3e21e130a16d044006656ee
ToppCell	P03-Epithelial-airway_epithelial_cell-club_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 CFAP54 DNAH12 EFCAB12 TTC29	8.30e-05	181	109	5	60a91587c59029a34e7bec1255083337fe21b72a
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Ciliated\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DNAH3 ECT2L DNAH12 TTC29 UGT2B17	8.30e-05	181	109	5	8eed9d46d924b16f6dd1a025ff612244b02b4391
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 TTC29	8.52e-05	182	109	5	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH3 ECT2L CFAP54 DNAH12 TTC29	8.52e-05	182	109	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCC1 LPIN1 NRXN3 GUCY1A2 TTC29	8.52e-05	182	109	5	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 ECT2L DNAH12 EFCAB12 TTC29	8.75e-05	183	109	5	b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|367C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 ECT2L DNAH12 EFCAB12 TTC29	8.75e-05	183	109	5	cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 TTC29	8.97e-05	184	109	5	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 MUC16 ECT2L CFAP54 DNAH12	9.20e-05	185	109	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	DNAH3 ECT2L DNAH12 UGT2B17 SEC14L4	9.20e-05	185	109	5	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 ECT2L CFAP54 DNAH12 TTC29	9.44e-05	186	109	5	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ECT2L CFAP54 DNAH12 TTC29	9.44e-05	186	109	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 ECT2L CFAP54 DNAH12 TTC29	9.44e-05	186	109	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DNAH3 ECT2L CFAP54 DNAH12 TTC29	9.93e-05	188	109	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.02e-04	189	109	5	057d7a03fdbe779122b203619a6f947f49b84d28
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.02e-04	189	109	5	9f57a131902d23494bf389baf6e6e2d99f88b2c8
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.02e-04	189	109	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.02e-04	189	109	5	e443b02502edaefa94567a9e8af5756e8e11ff30
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH3 MUC16 ECT2L DNAH12 TTC29	1.07e-04	191	109	5	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH3 MUC16 ECT2L DNAH12 TTC29	1.07e-04	191	109	5	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH3 MUC16 ECT2L DNAH12 TTC29	1.07e-04	191	109	5	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B AR ADCY8 FREM2 NRXN3	1.10e-04	192	109	5	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.10e-04	192	109	5	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.10e-04	192	109	5	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.12e-04	193	109	5	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.12e-04	193	109	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.12e-04	193	109	5	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	ASK440-Epithelial-Ciliated\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.12e-04	193	109	5	a0baa8be6f590b2031fede22be588715ae458e93
ToppCell	ASK440-Epithelial-Ciliated\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.15e-04	194	109	5	c84a7fa94fb06e08aae04db56c8c313b0afde1d7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 ECT2L CFAP54 DNAH12 TTC29	1.18e-04	195	109	5	0e763f36786515698b593e5c93f6a56619c1242d
Drug	LY215840	HTR2A HTR2B CACNA1I	3.79e-06	7	110	3	CID000132049
Drug	3-isoreserpine	ABCC1 HTR2A HTR2B ADCY8 ABCG4 ABCG1 SF3B1 SLC18A1	4.02e-06	190	110	8	CID000005052
Drug	minaprine	HTR2A HTR2B MYO1D FANCD2 FCAMR	6.29e-06	54	110	5	CID000004199
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	3.90e-05	3	107	2	EFO_0800574
Disease	Colorectal Carcinoma	UNC13B TBX22 ABCC1 DNAH3 ADCY8 LPIN1 PARP1 ABCG1 GUCY1A2 SACS CCAR1	5.00e-05	702	107	11	C0009402
Disease	X-25937 measurement	UGT2B15 UGT2B17	7.78e-05	4	107	2	EFO_0800937
Disease	Vitamin A Deficiency	LRAT PARP1	1.29e-04	5	107	2	C0042842
Disease	COVID-19, obesity	ADCY8 ATP2A1	2.70e-04	7	107	2	EFO_0001073, MONDO_0100096
Disease	X-24574 measurement	UGT2B15 UGT2B17	2.70e-04	7	107	2	EFO_0800897
Disease	heart disease (implicated_via_orthology)	KAT2A KAT2B ATP2A1	3.57e-04	38	107	3	DOID:114 (implicated_via_orthology)
Disease	deoxycholic acid glucuronide measurement	UGT2B15 UGT2B17	3.60e-04	8	107	2	EFO_0800575
Disease	Mood Disorders	HTR2A PFKL AR ADCY8 KAT2B	3.75e-04	168	107	5	C0525045
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	5.75e-04	10	107	2	EFO_0022090
Disease	Mammary Neoplasms	ABCC1 ACVR1 NUDT17 ADAR AR PARP1 GUCY1A2 CTCF	6.82e-04	527	107	8	C1458155
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	7.01e-04	11	107	2	EFO_0801531
Disease	basal cell carcinoma (is_implicated_in)	PTCH1 CTCF	8.40e-04	12	107	2	DOID:2513 (is_implicated_in)
Disease	triacylglycerol 58:12 measurement	NRXN3 TTC29	8.40e-04	12	107	2	EFO_0010439
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	8.40e-04	12	107	2	EFO_0800291
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	9.90e-04	13	107	2	EFO_0800293
Disease	X-19141 measurement	UGT2B15 UGT2B17	9.90e-04	13	107	2	EFO_0800799
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	1.15e-03	14	107	2	EFO_0800283
Disease	amyotrophic lateral sclerosis, age at onset	NRXN3 SLC18A1	1.33e-03	15	107	2	EFO_0004847, MONDO_0004976
Disease	Alopecia, Male Pattern	AR PARP1	1.33e-03	15	107	2	C4083212
Disease	Androgenetic Alopecia	AR PARP1	1.33e-03	15	107	2	C0162311
Disease	hepcidin:transferrin saturation ratio	PDHB MUC16	1.33e-03	15	107	2	EFO_0007902
Disease	Female pattern alopecia (disorder)	AR PARP1	1.33e-03	15	107	2	C0263477
Disease	Leber congenital amaurosis	LRAT RD3	1.51e-03	16	107	2	cv:C0339527
Disease	Schizoaffective disorder-bipolar type	PTCH1 NRXN3	1.51e-03	16	107	2	EFO_0009965
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	1.92e-03	18	107	2	EFO_0800288
Disease	neurodegenerative disease (implicated_via_orthology)	PTCH1 FIG4 UBR3 CDNF	1.95e-03	145	107	4	DOID:1289 (implicated_via_orthology)
Disease	Pseudopelade	AR PARP1	2.14e-03	19	107	2	C0086873
Disease	Alopecia	AR PARP1	2.14e-03	19	107	2	C0002170
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	2.14e-03	19	107	2	EFO_0800362
Disease	parental longevity	BICRA SNX29 CHRNB4 ABCG1 NAA25 GUCY1A2 CDNF	2.19e-03	494	107	7	EFO_0007796
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	2.37e-03	20	107	2	EFO_0800317
Disease	esophagus squamous cell carcinoma (is_marker_for)	PTCH1 CHRNB4 KAT2B	2.49e-03	74	107	3	DOID:3748 (is_marker_for)
Disease	Autistic Disorder	HTR2A MYO1D AR NRXN3 ADSL	2.66e-03	261	107	5	C0004352
Disease	X-24947 measurement	UGT2B15 UGT2B17	2.87e-03	22	107	2	EFO_0800910
Disease	Leber Congenital Amaurosis	LRAT RD3	2.87e-03	22	107	2	C0339527
Disease	schizophrenia (is_implicated_in)	HTR2A SLC18A1 CACNA1I	2.90e-03	78	107	3	DOID:5419 (is_implicated_in)
Disease	Mammary Carcinoma, Human	ABCC1 ACVR1 NUDT17 ADAR AR PARP1 GUCY1A2	3.06e-03	525	107	7	C4704874
Disease	Mammary Neoplasms, Human	ABCC1 ACVR1 NUDT17 ADAR AR PARP1 GUCY1A2	3.06e-03	525	107	7	C1257931
Disease	HbA1c measurement	PAQR9 ABCC1 PFKL FREM3 ABCG4 NAA25 PMPCA FIG4	3.23e-03	675	107	8	EFO_0004541
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	PTCH1 SNX29 ZMIZ2 CACNA1I KLC1 PPP1R16A	3.34e-03	398	107	6	EFO_0003756, EFO_0003888, EFO_0004337
Disease	lung squamous cell carcinoma (is_implicated_in)	PTCH1 CHRNB4	3.41e-03	24	107	2	DOID:3907 (is_implicated_in)
Disease	Breast Carcinoma	ABCC1 ACVR1 NUDT17 ADAR AR PARP1 GUCY1A2	3.50e-03	538	107	7	C0678222
Disease	obsolete_red blood cell distribution width	CCDC117 PAQR9 ABCC1 TRIM15 MYO1D FREM3 EPG5 PMPCA FIG4 UGT2B15 SLC15A5 SEC14L4	3.55e-03	1347	107	12	EFO_0005192

Protein segments in the cluster

Peptide	Gene	Start	Entry
IDMVLMTPTASMDDF	CHRNB4	181	P30926
SRVMPMTIQFSILIM	ADCY8	736	P40145
EMKMAEMRPPLIETS	ERBIN	606	Q96RT1
PETRSMIVCLLFMMI	EPG5	2111	Q9HCE0
MLLPHLTVLEAMMVS	ABCG4	151	Q9H172
FVMPIALLTIMFEAM	HTR2B	106	P41595
KMIESMSRPSMELVL	CCDC117	196	Q8IWD4
EITLSMLKSMLLMEA	CFAP54	2261	Q96N23
PEIQATMRELSKEMM	CHMP3	121	Q9Y3E7
SHKPATMTIMVEDIM	C19orf12	6	Q9NSK7
SSVQMVMMEQLDPTL	CTCF	56	P49711
LSEVTRPMSVHMPAM	CDNF	96	Q49AH0
DMLLPHLTVQEAMMV	ABCG1	166	P45844
SAKVMLMASPSMEDL	CCAR1	446	Q8IX12
MLLGFLVMPVSMLTI	HTR2A	121	P28223
LPIEACVMMLLSEGM	SH3BP1	291	Q9Y3L3
MVDGVMILPVLIMIA	ACVR1	1	Q04771
MLALAMVSLEMEKLI	CCNI	201	Q14094
MLISSRIPAYEMVME	ECT2L	291	Q008S8
RKVLPTTMMFSMLAD	C5orf64	101	Q2M2E5
VDTQMETRPMTLEEM	EFCAB12	316	Q6NXP0
PMTMALSVLVTIEMC	ATP2A1	896	O14983
TPESMLLAALMIVSM	ERVK-21	71	P61571
LMSLADLQDMSPMLL	PADI1	171	Q9ULC6
TMRTLDLLAMEPGMV	INTS8	216	Q75QN2
MGDIPMELVNEVMLT	KAT2A	451	Q92830
DSLRMAIMVQSPMFD	PARP1	31	P09874
MSLLVDGDMNLSIIM	SLC10A4	186	Q96EP9
LPTSSIMTESAEMMI	MUC16	8186	Q8WXI7
LFTPVMMKTTDMLDT	MUC16	8886	Q8WXI7
MMKTTDMLDTSLEPV	MUC16	8891	Q8WXI7
INMRTIRPMDMETIE	PDHB	266	P11177
IRPMDMETIEASVMK	PDHB	271	P11177
ISFSSVTVPKMLMDM	OR1J2	71	Q8NGS2
MALPFALMMALVVLS	IFNA14	1	P01570
MESDMALVKDMELPT	MAP4	296	P27816
ESSPRARLLIVMEMM	MAPKAPK5	91	Q8IW41
MGDIPMELINEVMST	KAT2B	446	Q92831
MSTLLRMIPTMAEDK	NUDT17	261	P0C025
TVRDLMPKTIMHLMI	DNM1	676	Q05193
NQLDIISMAETTMMP	BMERB1	36	Q96MC5
ISMAETTMMPEEIEL	BMERB1	41	Q96MC5
MMMEVDQFVLTALTP	FREM2	326	Q5SZK8
MDMAYISVTVPKMLL	OR2T4	101	Q8NH00
MPALIAMSCEETMLV	OR2W5P	181	A6NFC9
MGMEAVMALLEATPD	PFKL	316	P17858
IVPMMRSESMEITES	FRYL	921	O94915
IIMPMVMHTEAEDVS	NRXN3	696	Q9Y4C0
IQMSPQMSLIFETMD	DNAH12	1646	Q6ZR08
MFPIEMSSDEAMELL	LPIN1	181	Q14693
AHMMPDILLALTDDM	LRAT	71	O95237
HMVSVDFPEMMAEII	AR	886	P10275
DMSISSIIVPRLMMN	OR10G3	71	Q8NGC4
VAQTIPQMLAMMVDL	IPO5	301	O00410
VFVMPLSMACPIMLE	PAQR9	246	Q6ZVX9
METVQELIPLAKEMM	G0S2	1	P27469
TLAPVSTMLALFMLM	FCAMR	451	Q8WWV6
MMLNSDTMELDLPPT	NHLH1	1	Q02575
MANPTALLLSAVMML	IDH3A	301	P50213
ADLVAVVEMMQPMAA	GSTT4	166	A0A1W2PR19
DAMRINPSAEMVMID	BICRAL	781	Q6AI39
GMISESLDNLESMMP	ADAR	696	P55265
LMKSIVDYILMDPME	DNAH3	291	Q8TD57
MDMFSLDMIISDPAA	DENND2A	1	Q9ULE3
VLRMPLEMLKSEMTQ	FIG4	181	Q92562
MMVDPLLTKYSVIML	DHX35	161	Q9H5Z1
IMMAILVNTVSMGIE	CACNA1I	646	Q9P0X4
LAANSEVLMMLPRAM	GPR148	301	Q8TDV2
TPESMLLAALMIVSM	ERVK-21	71	P61565
LCSLPSERTMMMDII	FMO2	396	Q99518
VSPSAEMVMIDRMFI	BICRA	1166	Q9NZM4
ARLMVMVRQEESLMP	EHD1	391	Q9H4M9
IEMALMVFDMEGLSL	SEC14L4	146	Q9UDX3
ALVLLIPFMSMLMAV	SLC15A5	221	A6NIM6
ITDIPIIMSREFMIM	SACS	1566	Q9NZJ4
TELVKSPSEYLMMLM	POLR3E	236	Q9NVU0
LLELVVLNPSAMMMN	FANCD2	496	Q9BXW9
LEMLELGLSEAQVMM	KLC1	76	Q07866
IVPLMNDMSKLISEM	NOC3L	366	Q8WTT2
DTVDSMIPEVIKMFM	ABCC1	1081	P33527
LMALKMMELSEEVLT	GUCY1A2	591	P33402
ATMMMEVDPLVLTAL	FREM3	311	P0C091
LTSMLMMNLESRPVI	PMPCA	431	Q10713
VSIMAEAMKSPHIME	SERAC1	341	Q96JX3
ADAMEMMILSILAPQ	SVOP	96	Q8N4V2
FVMDEERSSMLPTMA	SNX29	151	Q8TEQ0
VDKLMPVIMIIMRDH	GFPT1	601	Q06210
VTLRVSMLDAIPMML	NBEAL2	301	Q6ZNJ1
MLKMAEPIASLMIVE	PRDM11	1	Q9NQV5
ELPFMATENIIMAMV	ADSL	376	P30566
ELLAEMPMVGRMSTQ	PPP1R16A	6	Q96I34
IVMVLALMTVELFGM	PTCH1	1056	Q13635
AVMVRLMLVLAPVMC	STT3A	401	P46977
ASAMPSRLMMEHVLL	NOM1	411	Q5C9Z4
PAEMVLETLMMELTG	RD3	21	Q7Z3Z2
VMDMLHSMGPDTVVI	PDXK	171	O00764
ILPMMVAVILANMVA	CLCN1	556	P35523
LATMISTMRPDIDNM	SF3B1	606	O75533
QSLAPLMMEVPMLSS	TBX22	401	Q9Y458
LMMEVPMLSSLGVTN	TBX22	406	Q9Y458
MLILMSSMGERILDA	SYCP2	196	Q9BX26
ILTLPEMMRMFSENL	TRIM15	271	Q9C019
MNTMERMIVLPPLTD	UNC13B	1301	O14795
PGVHTEALMITLEMM	SLF1	1036	Q9BQI6
VSPAHVLMPSVMEMI	ZMIZ2	706	Q8NF64
LLDIMVTVLLYMMES	UBR3	466	Q6ZT12
FDTTVELMSMPLMDE	TTC29	381	Q8NA56
MLERNLTSMMSVEEP	ZNF818P	1	Q6ZRF7
PVVMSELSDQMIFME	UGT2B15	196	P54855
MDIALTEPLTMEKMS	SOHLH2	116	Q9NX45
PPETASIMLMARMVA	SMYD5	161	Q6GMV2
MESEMMEILSVLAKG	UNC45A	901	Q9H3U1
VIPMDRSMLESMLNR	ZMYM3	1336	Q14202
PVVMSELSDQMIFME	UGT2B17	196	O75795
QSSMMPFTLEELIML	UBE3C	531	Q15386
VDSSMMPIMGHLVDL	SLC18A1	406	P54219
LMDTVSMPEFMANLR	MYO1D	16	O94832
TMFLPLAERMVEKMV	NAA25	171	Q14CX7